Th e commentary by Dr Walsh [1] discussed our study in a systematic way and highlighted several important aspects in relation to our analysis. Indeed, our study has limitations that we acknowledged in our paper. It should be noted, however, that the Transfusion Requirements in Critical Care (TRICC) study [2] excluded cardiac surgical patients and patients who had received blood transfusions before ICU admission. Th us, surgical patients who received intraoperative transfusions were probably excluded. Th e results of the TRICC study may not, therefore, be extrapolated to surgical ICU patients. Hence, we do not agree with Dr Walsh that the current evidence is consistent with hemoglobin triggers less than 9 g/dL in surgical ICU patients. In the absence of large cohort studies and randomized controlled trials in this specifi c subgroup of ICU patients, the results of our study should be considered relatively robust pending the results of future randomized controlled trials. We agree with Dr Walsh, however, that more TRICCs are needed, hopefully designed to include diff erent case mixes and avoiding the 'one size fi ts all' concept. It may also be necessary to think outside the box. Hemoglobin levels are not the only determinant of oxygen delivery to the tissues and are not expected to refl ect tissue perfusion or cellular metabolic needs. A successful transfusion strategy should consider all these factors and should not be minimized to the simple question, 'which hemoglobin level should be targeted?' but to the more relevant question 'could this specifi c patient benefi t from blood transfusion in this specifi c clinical situation?' Abbreviations TRICC = Transfusion Requirements in Critical Care.
